This cross-sectional observational study included OAG patients who visited Samsung Medical Center (Seoul, South Korea) for their first ophthalmic examination between January 2015 and March 2017. This study followed all guidelines for experimental investigation in human subjects, was approved by the Samsung Medical Center Institutional Board, and adhered to the tenets of the Declaration of Helsinki.
Each patient underwent a comprehensive ophthalmic examination, including slit-lamp biomicroscopy, Goldmann applanation tonometry, manifest refraction, gonioscopic examination, color fundus photography (TRC-50DX; Topcon Medical System, Inc., Oakland, NJ, USA), automated perimetry using a central 30-2 Humphrey Field Analyzer (HFA model 640; Humphrey Instruments, Inc., San Leandro, CA, USA) with the Swedish interactive threshold algorithm standard, AL measurement (IOL Master; Carl Zeiss Meditec, Jena, Germany), and ultrasound pachymetry (Tomey SP-3000; Tomey Ltd., Nagoya, Japan). The extent of VF defect was measured using mean deviation (MD), pattern standard deviation (PSD), and visual field index (VFI). Reliability VF analysis was defined as a false-negative rate < 15%, false-positive rate < 15%, and fixation loss < 20%. IOPs were measured at the first and second visits without IOP-lowering medications. Average IOP values were used in the analysis.
The following criteria were required for diagnosis of OAG: (1) glaucomatous optic disc changes, such as increased cupping (vertical cup-to-disc ratio > 0.7), diffuse or focal neural rim thinning, disc hemorrhage, or RNFL defects at diagnosis; (2) glaucomatous VF defects positive by more than one reliable test for at least two of the following three criteria: (a) a cluster of three points with a probability <5% on the pattern deviation map in at least one hemifield, including at least one point with a probability less than 1% or a cluster of two points with a probability less than 1%; (b) a glaucoma hemifield test result outside the normal limits; or (v) a PSD of 95% outside the normal limits; and (3) an open angle on gonioscopic examination confirmed to have no identified causes of secondary glaucoma present. The exclusion criteria were eyes with media opacities, such as a corneal or vitreous opacity, moderate to severe cataract; systemic disease or ocular diseases that could affect VF test results; high myopia with AL > 28 mm that can have myopic degeneration or retinal schisis around the ONH; and baseline MD of −12 dB or less, for which glaucomatous VF pattern would be difficult to be determined on a VF test. If the patient has OAG in both eyes, then only the eye with less severe MD was included in the analysis.